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OBJECTIVES To examine whether the gender difference in coronary artery calcification, a measure of
atherosclerotic plaque burden, is lost in type 1 diabetic patients, and whether abnormalities in
established coronary heart disease risk factors explain this.
BACKGROUND Type 1 diabetes abolishes the gender difference in coronary heart disease mortality because it
is associated with a greater elevation of coronary disease risk in women than men. The
pathophysiological basis of this is not understood.
METHODS Coronary artery calcification and coronary risk factors were compared in 199 type 1 diabetic
patients and 201 nondiabetic participants of similar age (30 to 55 years) and gender (50%
female) distribution. Only one subject had a history of coronary disease. Calcification was
measured with electron beam computed tomography.
RESULTS In nondiabetic participants there was a large gender difference in calcification prevalence (men
54%, women 21%, odds ratio 4.5, p , 0.001), half of which was explained by established risk
factors (odds ratio after adjustment 5 2.2). Diabetes was associated with a greatly increased
prevalence of calcification in women (47%), but not men (52%), so that the gender difference
in calcification was lost (p 5 0.002 for the greater effect of diabetes on calcification in women
than men). On adjustment for risk factors, diabetes remained associated with a threefold
higher odds ratio of calcification in women than men (p 5 0.02).
CONCLUSIONS In type 1 diabetes coronary artery calcification is greatly increased in women and the gender
difference in calcification is lost. Little of this is explained by known coronary risk factors. (J
Am Coll Cardiol 2000;36:2160–7) © 2000 by the American College of Cardiology
Patients with type 1 diabetes have greatly elevated risks of
coronary heart disease (CHD) (1). The elevation in risk
compared to the general population is greater for women
than men, so much so that the gender difference in CHD
mortality is lost in patients with diabetes (2). Case-fatality
rates for myocardial infarction and diabetic cardiomyopathy
rates are higher in diabetic women than men but these
factors alone are unlikely to explain the loss of the gender
difference in CHD mortality (3,4). Whether the gender
difference in coronary atherosclerosis itself is lost in diabetes
is an important clinical question because strategies for
reducing post-infarct mortality are different from those for
reducing atherosclerosis. Definitive data on this question are
sparse and conflicting. A greater increase in thoracic artery
atherosclerosis in young hyperglycemic women than men
has been observed at autopsy (5), but the gender difference
in carotid intima-medial thickness is apparently preserved in
patients with diabetes (6).
The increased risk of CHD in patients with diabetes is in
part mediated through an elevation in established coronary
risk factors. A possible explanation for the loss of the gender
difference in CHD in patients with type 1 diabetes could be
that the difference in coronary risk factors between those
with and without diabetes is greater for women than men.
Alternatively the effect of a given risk factor might be
greater in the presence of diabetes in women but not in men.
Establishing whether this is the case is important for the
appropriate development of CHD prevention and therapeu-
tic strategies in patients with diabetes.
The amount of coronary artery calcification (CAC) has a
very high correlation (r . 0.9) with coronary atherosclerotic
plaque burden, making it a useful measure of the extent of
coronary atherosclerosis (7). Coronary artery calcification is
accurately quantified by electron beam computerized to-
mography scanning (EBCT). The objectives of this study
were to determine whether diabetes is associated with a loss
of the gender difference in coronary artery calcification and,
if so, to examine whether this could be explained by
established coronary risk factors.
METHODS
Subjects. A random sample of type 1 diabetic men and
women aged 30 to 55 years was taken from the diabetes
registers of five London hospitals. Type 1 diabetes was
defined by age of onset #25 years and insulin treatment
within one year of diagnosis. A random sample of the
general population, stratified to have a similar age and
gender distribution to the patients with diabetes, was drawn
from the lists of two London general practices. Subjects
were included regardless of any history of heart disease.
Pregnant women and patients on renal replacement therapy
were excluded. Of 1,450 letters sent, 22% were returned as
addressee unknown or gone away. Of the remainder, 53% of
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patients with diabetes (57% of men, 49% of women) and
30% of the nondiabetic group (31% of men, 30% of women)
agreed to take part. In all, 199 type 1 diabetic patients (95
women) and 201 nondiabetic men and women (107
women) were examined. Ethics Committee approval was
obtained. All participants gave fully informed written con-
sent prior to participation, having received full details of the
study procedures.
Examination. Participants completed a standardized ques-
tionnaire. The average weekly consumption of alcohol units
was calculated and smoking exposure was quantified in pack
years. The duration and intensity of weekly walking, cycling,
sporting and occupational activity was used to define low or
high physical activity (below vs. at least 10 MJ energy
expenditure per week) (8). Daily insulin dose was also
noted. Three supine blood pressure (BP) recordings were
made after 5 min rest using an Omron 705c oscillometric
device. The mean of the second and third readings was used.
Hypertension was defined as having a systolic BP
$140 mm Hg or a diastolic BP $90 mm Hg or being on
antihypertensive drugs. Obesity was defined as a body mass
index (BMI) $30 kg/m2. Waist and hip circumference were
also recorded. The examiners were aware of the diabetic
status of the participants.
EBCT scan. An Ultrafast CT scanner (IMATRON
C-150XL) was used to quantify coronary calcification. Two
sets of 20 transverse tomograms of 3-mm thickness were
obtained from the lower margin of the bifurcation of the
right branch of the pulmonary artery to the apex of the heart
with the subject breathholding. A radiologist placed a
region of interest around each potentially calcific lesion
(peak density .130 Hounsfield U) within the right coro-
nary, circumflex, left anterior descending and left main
coronary arteries. The area and peak density of each lesion
was measured. A density score of 1 to 4 was defined based
on the peak density of the lesion; calcification score was then
calculated as the product of the area of the lesion and its
density score as described (9).
To be included in the calcification score a lesion had to
have an area of at least 0.51 mm2, i.e., two contiguous pixels
and a peak density of at least 130 Hounsfield U. A total
score for each artery and for the entire heart was calculated
by summing the lesion scores. The radiation exposure was
,1 mSv. All scans were scored by the same radiologist, who
was blinded to the gender and the diabetes status of the
subject. Based on a small repeatability study (n 5 20) the
within-observer agreement for the presence of any calcifi-
cation was high (kappa 5 0.84).
Laboratory methods. After an overnight fast, blood sam-
ples were taken from patients and total cholesterol, high-
density lipoprotein (HDL) cholesterol and triglycerides
were measured using standard enzymatic colorimetric meth-
ods (intra-assay coefficient of variation [CV] 5 1.6%, 2.6%
and 2% respectively). HDL cholesterol was measured di-
rectly after stabilization of other lipoproteins and low-
density lipoprotein (LDL) cholesterol was calculated by the
Friedewald equation. HbA1c was measured with a latex
enhanced immunoassay (intra-assay CV 1.7%). Urinary
albumin excretion was calculated from two timed overnight
urine collections. Women who were menstruating were
excluded from urinary albumin analyses (n 5 54). Urinary
albumin was measured with an immunoturbidimetric
method (intra-assay CV 2.3%).
Statistical methods. Analyses were carried out with Stata
5. We examined whether there were differences in risk
factors between diabetic and nondiabetic participants using
multiple linear regression and logistic regression, adjusted
for age. We tested whether the difference in risk factors
between those with and without diabetes was the same for
men and women by including a diabetes-by-gender inter-
action term in these models. This is equivalent to testing
whether the gender difference in risk factors is altered by
diabetes. Calcification scores (for the total heart) were
positively skewed with a high frequency of zero values (Fig.
1). As data transformation would not have normalized this
distribution, we used the nonparametric Mann Whitney U
test to test for differences in coronary calcification score
between those with and without diabetes for each gender.
Logistic regression was used to examine the odds of having
any calcification (a score .0) associated with diabetes,
adjusting for covariates. All covariates were entered into the
Abbreviations and Acronyms
AER 5 Albumin excretion rate
BMI 5 body mass index
BP 5 blood pressure
CAC 5 coronary artery calcification
CHD 5 coronary heart disease
CV 5 coefficient of variation
EBCT 5 electron beam computerized tomography
HDL 5 high-density lipoprotein
LDL 5 low-density lipoprotein
Figure 1. The cumulative frequency of coronary artery calcification score
by diabetes status and gender.
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models simultaneously. We tested whether the odds of any
calcification associated with diabetes were the same in men
and women by including a diabetes-by-gender interaction
term in the model. We examined whether the strength of
the association between risk factors and coronary calcifica-
tion, for a given level of the risk factor, was the same across
the four diabetes-gender groups by including a risk factor-
by-diabetes-gender category interaction term.
The effect of adjusting for these factors on the diabetes–
gender interaction for calcification was also examined. The
risk factors considered in these models are shown in Table
1. The correlation between body fat and BMI differs
between men and women so that the validity of adjusting
gender differences for BMI is debatable. Therefore the effect
of adjusting for BMI in the above models is described
separately. Risk factors with skewed distributions were
normalized by the appropriate transformation before anal-
ysis.
RESULTS
Risk factor distribution by diabetes status and gender.
One participant (a woman with diabetes) had a history of
angina; none had had a myocardial infarction. Men and
women with diabetes had higher HDL-cholesterol, lower
LDL-cholesterol and lower triglycerides and total:HDL-
cholesterol ratios than nondiabetic subjects (Table 1). Ex-
clusion of the three subjects on lipid-lowering drugs did not
affect this result. On adjustment for obesity, the differences
in lipid profile between those with and without diabetes
were unchanged in men but were attenuated to non-
significance in women. This difference between men and
women in the effect of diabetes was significant for total:
HDL-cholesterol ratio (p 5 0.04) and triglycerides (p 5
0.03) but not LDL-cholesterol (p 5 0.2) or HDL-
cholesterol (p 5 0.6). A higher daily insulin dose per unit
BMI was observed in men than women (Table 1, p 5 0.001
for the gender difference). However, a higher insulin dose
was associated with a higher total:HDL-cholesterol ratio
(correlation coefficient r 5 0.24, p , 0.001). Thus sex
differences in insulin dose cannot underlie the observation
that diabetes is associated with a lower total:HDL choles-
terol ratio in men but not in women.
The difference in BP between those with and without
diabetes was greater in women (18 mm Hg for systolic BP)
than in men (14 mm Hg, p 5 0.08 for the interaction for
systolic BP, p 5 0.02 for diastolic BP). On adjustment for
obesity this difference between men and women in the effect
of diabetes on systolic BP was 5 mm Hg (p 5 0.03 for the
interaction). Few subjects were on blood-pressure-lowering
drugs (2 nondiabetic men, 13 diabetic men, 3 nondiabetic
women, 13 diabetic women). Thus the gender difference in
the effect of diabetes on BP is not likely to be an artifact
attributable to differential hypertension treatment rates.
This was supported by the results of a censored regression
analysis in which the diabetes-by-gender interaction for BP
was examined with the BP in those on drugs affecting BP
Table 1. Sociodemographic and CHD Risk Factors According to Diabetes Status and Gender
Men Women
Nondiabetic Diabetic Nondiabetic Diabetic
n 94 104 107 95
Mean (SE)
Age (yrs) 37.8 (0.04) 38.2 (0.4) 37.9 (0.3) 37.5 (0.5)
Diabetes duration (yrs) — 23.1 (0.8) — 23.7 (0.8)
HbA1c % (Gm)§ 5.3 (0.04) 8.4 (0.12)‡ 5.3 (0.03) 8.9 (0.20)‡
Insulin dose per unit BMI/day 2.3 (0.07) 1.7 (0.05)
BMI kg/m2 25.0 (0.3) 25.4 (0.3) 25.6 (0.5) 25.3 (0.4)
WHR 0.92 (0.01) 0.91 (0.01) 0.81 (0.01) 0.82 (0.01)
HDL cholesterol mmol/l 1.6 (0.04) 1.7 (0.04)† 1.8 (0.04) 2.0 (0.05)*
LDL cholesterol mmol/l 3.3 (0.11) 3.0 (0.1)* 3.0 (0.08) 2.8 (0.09)
Total cholesterol:HDL ratio 3.8 (0.13) 3.2 (0.1)‡ 3.0 (0.09) 2.9 (0.09)
Triglyceride mmol/L (Gm) 1.4 (0.09) 1.2 (0.06)* 0.99 (0.05) 0.95 (0.04)
Systolic BP (mm Hg) 124 (1.3) 129 (1.1)* 111 (1.2) 120 (1.5)‡
Diastolic BP (mm Hg) 76 (1.0) 77 (0.8) 69 (0.8) 72 (0.9)*
% SE
% Obese 6 (2) 8 (3) 21 (4) 8 (3)†
% Hypertensive\ 20 (4) 27 (4) 6 (2) 16 (4)*
% AER $20 mg/min 4 (2) 22 (4)† 3 (2) 9 (3)
% Ever smoked 56 (5) 50 (5) 48 (5) 45 (5)
% Left school ,19 yrs 63 (5) 44 (5)† 65 (5) 54 (5)
% Exercise score ,10 73 (5) 82 (4) 86 (4) 85 (4)
% Drinking above 21 U/wk 40 (5) 24 (4)* 7 (3) 11 (3)
*p , 0.05; †p , 0.01; ‡p , 0.001 for the difference between those of the same gender with and without diabetes adjusted for
age using regression analysis; §Gm 5 geometric mean; \Hypertension 5 systolic BP $ 140 mm Hg or diastolic BP $ 90 mm Hg
or on treatment.
SE 5 standard error; AER 5 albumin excretion rate; BMI 5 body mass index; BP 5 blood pressure;
HDL 5 high-density cholesterol; LDL 5 low-density cholesterol.
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censored to the right (p 5 0.05 for the interaction for
systolic BP, p 5 0.009 for the interaction for diastolic BP).
For the remaining risk factors, the diabetes-associated
difference was similar in both genders. Adjustment for
educational status, which differed between those with and
without diabetes, did not affect any of these results.
CALCIFICATION SCORES. The cumulative frequency of cal-
cification scores is shown in Figure 1. In the nondiabetic
group there was a large gender difference in the prevalence
of calcification (Table 2). In men diabetes was not associ-
ated with a higher prevalence of calcification, although
among all men with calcification its severity was greater in
those with diabetes (p 5 0.04 Mann Whitney U test). In
women diabetes was associated with both a greatly elevated
severity of calcification (p 5 0.0001 Mann Whitney U test)
and prevalence of calcification (Table 2). Thus the odds
ratio for calcification associated with diabetes was 3.9 times
higher in women than men, adjusted for age (p 5 0.002 for
this diabetes-by-gender interaction), and as a result the
gender difference in calcification prevalence was abolished in
diabetic subjects. Adjustment for educational status did not
affect this result.
RISK FACTORS ASSOCIATED WITH CORONARY CALCIFICA-
TION. The association between risk factors and calcification
adjusted for age is shown in Table 3. The strength of the
associations of the various risk factors with calcification was
similar among the four diabetes-gender groups for most risk
factors, though our power to detect small differences in
effect was limited. The odds ratios for alcohol consumption
and physical activity differed significantly between diabetic
women and nondiabetic men. The importance of this is
doubtful, as the confidence intervals for these odds ratios
were wide.
RISK FACTORS UNDERLYING THE GENDER DIFFERENCE IN
CALCIFICATION IN THE NONDIABETIC GROUP. In the non-
diabetic group adjustment for systolic BP, total cholesterol:
HDL cholesterol, alcohol consumption and smoking re-
duced the gender difference in calcification by 30%, 18%,
24% and 5%, respectively. On adjustment for these factors
simultaneously, men continued to have a twofold odds of
calcification compared with women (odds ratio 5 2.2 95%
CI 1.02–5, p 5 0.04). Adjustment for BMI increased the
odds ratio to 6.3 (95% CI 2.3–17, p , 0.001). None of the
other risk factors listed in Table 1 contributed to the gender
difference in calcification.
CONTRIBUTION OF RISK FACTORS TO THE LOSS OF THE
GENDER DIFFERENCE IN CALCIFICATION IN DIABETES.
This was explored by examining the effect of adjustment for
risk factors on the 3.9-fold higher odds ratio for calcification
associated with diabetes in women than men. Adjustment
was made for risk factors where the difference between those
with and without diabetes was found to differ by gender
(i.e., BP, total:HDL-cholesterol ratio, glycemic control).
On adjustment, the diabetes-associated odds ratio for cal-
cification remained higher in women than men (threefold
higher, p 5 0.02). On adjustment for BMI, this increased to
a sixfold higher odds ratio. Further adjustment for alcohol
consumption, physical activity and other risk factors did not
change this.
Which risk factors were associated with the much higher
odds of calcification in diabetic than nondiabetic women
was also examined. Adjusting for systolic BP reduced the
odds ratio for calcification in diabetic compared with non-
diabetic women from 3.5 to 2.5 (95% CI 2–8, p , 0.001).
This suggests that BP elevation is part of the explanation for
increased calcification in diabetic compared with nondia-
betic women. However, adjustment for total: HDL-
cholesterol ratio, BMI and educational status increased the
odds ratio to 5.6 (95% CI 2.4–13, p , 0.001). Further
adjustment for other risk factors did not change this odds
ratio.
DISCUSSION
Summary of results. This is the first study in which gender
differences in both cardiovascular risk factors and a measure
of coronary atherosclerosis have been directly compared
between young type 1 diabetic patients and the general
population. We find that type 1 diabetes abolishes the
gender difference in coronary artery calcification and that
this is not explained by established CHD risk factors. This
study also demonstrates that much of the gender difference
in coronary calcification in the general population at this age
remains unexplained by established coronary risk factors.
THE GENDER DIFFERENCE IN CALCIFICATION IN NONDIA-
BETIC SUBJECTS. We first examined which factors were
important in the gender difference in calcification in the
nondiabetic group. The magnitude of the gender difference
in calcification in the nondiabetic group is consistent with
the 4 to 6-fold risk ratio for CHD mortality in men at this
age (10). About half of this gender difference was accounted
for by the risk factors measured, mainly BP and lipids. Of
course the contribution of known risk factors may be
underestimated because of measurement error and because
risk factors were only measured on a single occasion (11).
However, the magnitude of the remaining difference is such
that other risk factors must be involved.
Table 2. Prevalence of Coronary Calcification (Score . 0) by
Diabetes Status and Gender
Prevalence of Calcification
Odds Ratio for
Calcification in
Diabetic vs.
NondiabeticDiabetic Nondiabetic
Men 52% 54% 0.9 (0.5–1.6)
Women 47% 21% 3.5 (1.9–6.7)‡
Odds ratio for
calcification,
men vs. women
1.2 (0.7–2.0) 4.5 (2.4–6.5)‡
‡p , 0.001.
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ROLE OF RISK FACTORS IN THE LOSS OF THE GENDER
DIFFERENCE IN CAC IN PATIENTS WITH DIABETES. That
diabetes has a greater effect on calcification in women than
men suggests that diabetes may be associated with a greater
risk factor disturbance in women than men relative to the
general population. The obvious candidates are those risk
factors that are important in the gender difference in the
general population. We found that diabetes was associated
with a lower total:HDL-cholesterol ratio and triglycerides
in men but not in women. We also found that type 1
diabetes was also associated with a significantly greater
difference in BP in women than in men, despite a greater
prevalence of albuminuria in men. However, the greater
effect of diabetes on calcification in women than men was
not explained by these risk factors. Neither was it explained
by diabetes modifying the risk ratio associated with a given
level of a risk factor in women.
OTHER POSSIBLE EXPLANATIONS FOR THE LOSS OF THE
GENDER DIFFERENCE IN CALCIFICATION IN PATIENTS
WITH DIABETES. Other explanations must therefore be
sought for the dramatic difference in the effect of diabetes
on calcification in women compared with men. The total
cholesterol:HDL-cholesterol data suggest that investigation
of the role of more subtle alterations in lipids and lipopro-
teins, particularly related to triglyceride metabolism, such as
lipoprotein particle size, is warranted. Whether there is a
more profound adverse effect of diabetes on endothelial
function in women than men is also of interest and would be
consistent with our BP data. This is plausible because
gender differences in endothelial function (12), perhaps
mediated by estrogen, may contribute to the gender differ-
ence in atherosclerosis and because defective endothelial
function has been reported in uncomplicated type 1 diabetes
(13). It is also possible that data on these risk factors, e.g.,
glycemia, over a longer period might explain more of the
loss of the gender difference. Further studies are now
underway to test these hypotheses.
IMPORTANT DIFFERENCES BETWEEN TYPE 1 AND TYPE 2
DIABETES. In patients with type 2 diabetes there is also an
unexplained reduction in the gender difference in CHD
risk, but this study cautions against assuming that the
reasons will prove common to both types of diabetes. In type
2 diabetes HDL cholesterol is reduced and the gender
difference is attenuated (14,15). We found that the gender
difference in HDL cholesterol was maintained and indeed,
consistent with other studies, HDL cholesterol was higher
in type 1 diabetic than nondiabetic patients. The higher
HDL cholesterol in type 1 diabetic patients may be related
to increased lipoprotein lipase activity, possibly secondary to
insulin therapy (16). In type 2 diabetes there is a greater
elevation in central obesity in women than in men compared
with the nondiabetic population (15). We did not find any
attenuation of the gender difference in waist–hip ratio in
patients with type 1 diabetes, and diabetes was associated
with a lower prevalence of obesity in women but not in men.
Study validity. The response rate of 30% in the nondia-
betic group and 53% in the diabetic group raises the
possibility of selection bias. Our true response rate is
probably considerably higher than this, as it is likely that
many of the addresses from which there was no response at
all were no longer valid. In any case, the main conclusion of
the abolition of the gender difference in diabetes would only
be affected if the difference in response rates between the
diabetic and nondiabetic group differed by gender. This was
not the case. Furthermore, the distribution of risk factors in
the nondiabetic group was similar to that of the same
age-gender bands of the general population in the Health
Survey for England, which is consistent with the nondia-
betic sample being representative of the general population
in terms of CHD risk (17). Among the diabetic group the
prevalence of hypertension and albuminuria was similar to
that found in the United Kingdom patients in the EURO-
DIAB IDDM Complications Study (18). Observer bias is
also unlikely, as the examiners were blinded to the diabetic
status of participants for the EBCT scan scoring. Reverse
causation bias, which arises when there are changes in risk
factor levels following diagnosis of disease, is also unlikely.
Although we sampled people without regard to their car-
diovascular disease history, only one person had a clinical
diagnosis of angina and few had nephropathy.
THE VALIDITY OF CORONARY CALCIFICATION AS A MEA-
SURE OF CORONARY ATHEROSCLEROSIS. Our data demon-
strate unequivocally that there is a loss in the gender
difference in coronary artery calcification in diabetes. The
usefulness of EBCT defined CAC as a measure of athero-
sclerosis burden in the general population is well established
(19). Autopsy studies have demonstrated the amount of
calcification increases with the amount of atherosclerosis
(7,20). For example, the total calcium volume in the
coronary arteries was highly correlated with total plaque
volume (r 5 0.87, p , 0.0001) (7). In vivo studies are of
course restricted to angiographic studies of symptomatic
patients. These have also shown that CAC score is associ-
ated with the extent of luminal stenoses, though slightly less
strongly than with atherosclerotic plaque burden in autopsy
studies (19). However, luminal stenosis is itself not perfectly
correlated with atherosclerosis burden, probably because
diseased vessels enlarge to preserve lumen size (21), so that
the autopsy data are more relevant than the angiography
data to the validity of our study. Consistent with its being a
good marker of the amount of atherosclerotic plaque,
EBCT-defined CAC score is also an important predictor of
clinical events (22,23).
CALCIFICATION IS SIMILARLY RELATED TO ATHEROSCLE-
ROSIS IN MEN AND WOMEN. For our data to imply a loss in
the gender difference in coronary atherosclerosis requires
that coronary calcification be similarly related to coronary
atherosclerosis in women and men and in diabetic and
nondiabetic subjects. Importantly, a given calcification score
predicts a similar burden of plaque in male and female
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hearts at autopsy (24–26). Although one study concluded
that CAC score related differently to angiographic stenosis
in men than women, the comparison was made at the same
age rather than at the same degree of plaque (27).
THE RELATIONSHIP OF CALCIFICATION TO ATHEROSCLE-
ROSIS IN DIABETES. There are fewer data on whether
EBCT-defined CAC has the same association with athero-
sclerosis in diabetic and nondiabetic subjects. At autopsy,
plaques in type 1 diabetic subjects were found to have a
similar calcium content for a given amount of plaque as in
nondiabetic subjects (28). Of particular importance is that
type 1 diabetes is associated with medial calcification of the
peripheral vessels, raising the question of whether the
calcification we have observed in the coronary vessels could
be medial. However non-atherosclerotic medial calcification
is not common in the coronary tree (29). Those sporadic
reports of extensive medial coronary calcification have been
in patients with renal failure (30,31). Therefore it seems
likely that the CAC in these young diabetic patients without
renal failure is intimal and indicative of atherosclerosis. This
is further supported by the similar strength of the associa-
tion of CHD risk factors with CAC in the diabetic and
nondiabetic subjects in this study.
In summary, we have found that type 1 diabetes abolishes
the gender difference in coronary calcification which likely
reflects atherosclerosis. An important clinical implication is
that interventions aimed solely at reducing post-infarct
mortality in diabetic women are likely to have little impact
on the greater elevation of CHD mortality in diabetic
women than men. Strategies to prevent coronary atheroscle-
rosis are needed and the high prevalence of coronary
calcification despite the young age of our study participants
demonstrates that prevention must be instigated at an early
age. Reductions in BP, lipids and other established coronary
risk factors are important for reducing CHD in diabetic
patients. However, greater progress in our understanding of
the pathogenesis of atherosclerosis in diabetic women is
necessary for its effective prevention.
Acknowledgments
The authors are grateful to the fieldwork team and the
radiographers at the Harefield and Royal Brompton and
Harefield NHS Hospital Trust. We also wish to thank the
patients and volunteers who took part and their physicians.
Reprint requests and correspondence: Dr. Helen M. Colhoun,
EURODIAB, Department of Epidemiology and Public Health,
University College London Medical School, 1-19 Torrington
Place, London WC1E 6BT, United Kingdom. E-mail:
helen@public-health.ucl.ac.uk.
REFERENCES
1. Laing SP, Swerdlow AJ, Slater DS, et al. The British Diabetic
Association Cohort Study, II: Cause-specific mortality in patients with
insulin-treated diabetes mellitus. Diabetic Med 1999;16:466–71.
2. Krolewski AS, Kosinski EJ, Warram JH, et al. Magnitude and
determinants of coronary artery disease in juvenile-onset insulin-
dependent diabetes. Am J Cardiol 1987;59:750–5.
3. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG.
Influence of diabetes on mortality in acute myocdardial infarction: data
from the GISSI-2 Study. J Am Coll Cardiol 1993;22:1788–94.
4. Bell DSH. Diabetic Cardiomyopathy. A unique entity or a complica-
tion of coronary artery disease? Diabetes Care 1995;18 :708–14.
5. McGill HC, Jr., McMahan CA, Malcom GT, Oalmann MC, Strong
JP. Relation of glycohemoglobin and adiposity to atherosclerosis in
youth. Pathobiological Determinants of Atherosclerosis in Youth
(PDAY) Research Group. Arterioscler Thromb Vasc Biol 1995;15:
431–40.
6. Epidemiology of Diabetes Interventions and Complications (EDIC)
Research Group. Effect of intensive diabetes treatment on carotid
artery wall thickness in the epidemiology of diabetes interventions and
complications. Diabetes 1999;48:383–90.
7. Sangiorgi G, Rumberger JA, Severson A, et al. Arterial calcification
and not lumen stenosis is highly correlated with atherosclerotic plaque
burden in humans: a histologic study of 723 coronary artery segments
using nondecalcifying methodology. J Am Coll Cardiol 1998;31:126–
33.
8. Baecke JA, Burema J, Frijters JE. A short questionnaire for the
measurement of habitual physical activity in epidemiological studies.
Am J Clin Nutr 1982;36:936–42.
9. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M,
Detrano R. Quantification of coronary artery calcium using ultrafast
computed tomography. J Am Coll Cardiol 1990;15:827–32.
10. Wingard DL, Suarez L, Barrett-Connor E. The sex differential in
mortality from all causes and ischemic heart disease. Am J Epidemiol
1983;117:165–72.
11. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and
coronary heart disease. Part 1, prolonged differences in blood pressure:
prospective observational studies corrected for the regression dilution
bias. Lancet 1990;335:765–74.
12. Chowienczyk PJ, Watts GF, Cockcroft JR, Brett SE, Ritter JM. Sex
differences in endothelial function in normal and hypercholesterolae-
mic subjects. Lancet 1994;344:305–6.
13. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric
oxide synthesis in the human forearm arterial bed of patients with
insulin-dependent diabetes. J Clin Invest 1992;90:2548–54.
14. Barrett-Connor E, Witztum JL, Holdbrook M. A community study of
high density lipoproteins in adult non insulin-dependent diabetics.
Am J Epidemiol 1983;117:186–92.
15. Howard BV, Cowan LD, Go O, et al. Adverse effects of diabetes on
multiple cardiovascular disease risk factors in women. The Strong
Heart Study. Diabetes Care 1998;21:1258–65.
16. Taskinen MR, Kahri J, Koivisto V, Shepherd J, Packard CJ. Metab-
olism of HDL apolipoprotein A-I and A-II in type 1 (insulin-
dependent) diabetes mellitus. Diabetologia 1992;35:347–56.
17. Colhoun HM, Prescott-Clarke P. Health Survey for England 1994.
London: HMSO, 1996.
18. Koivisto VA, Stevens LK, Mattock MJ, et al. Cardiovascular disease
and its risk factors in IDDM in Europe. Diabetes Care 1996;19:689–
97.
19. Rumberger AJ, Brundage HB, Rader JD, Kondos G. Electron beam
computed tomography coronary calcium scanning: a review and
guidelines for use in asymptomatic persons. Mayo Clin Proc 1999;74:
243–52.
20. Eggen DA, Strong JP, McGill HC, Jr. Coronary calcification. Rela-
tionship to clinically significant coronary lesions and race, sex, and
topographic distribution. Circulation 1965;32:948–55.
21. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis
GJ. Compensatory enlargement of human atherosclerotic coronary
arteries. N Engl J Med 1987;316:1371–5.
22. Arad Y, Spadaro LA, Goodman K, et al. Predictive value of electron
beam computed tomography of the coronary arteries. 19-month
follow-up of 1173 asymptomatic subjects. Circulation 1996;93:
1951–3.
23. Raggi P, Callister TQ, Cooil B, et al. Identification of patients at
increased risk of first unheralded acute myocardial infarction by
electron-beam computed tomography. Circulation 2000;101:850–5.
24. Rumberger JA, Schwartz RS, Simons DB, Sheedy PF, Edwards WD,
Fitzpatrick LA. Relation of coronary calcium determined by electron
2166 Colhoun et al. JACC Vol. 36, No. 7, 2000
Coronary Calcification in Type 1 Diabetes December 2000:2160–7
beam computed tomography and lumen narrowing determined by
autopsy. Am J Cardiol 1994;73:1169–73.
25. Budoff MJ, Georgiou D, Brody A, et al. Ultrafast computed tomog-
raphy as a diagnostic modality in the detection of coronary artery
disease: a multicenter study. Circulation 1996;93:898–904.
26. Kajinami K, Seki H, Takekoshi N, Mabuchi H. Coronary calcification
and coronary atherosclerosis: site by site comparative morphologic
study of electron beam computed tomography and coronary angiog-
raphy. J Am Coll Cardiol 1997;29:1549–56.
27. Devries S, Wolfkiel C, Fusman B, et al. Influence of age and gender
on the presence of coronary calcium detected by ultrafast computed
tomography. J Am Coll Cardiol 1995;25:76–82.
28. Dziedzic Goclawska A, Fuchs U, Krautschick I, Ostrowski K, Sta-
chowicz W, Michalik J. Crystallinity of mineral deposited in arterial
walls in the course of arteriosclerosis in diabetics and in patients with
normal carbohydrate metabolism. Basic Appl Histochem 1984;28:
21–8.
29. Blankenhorn DH. Coronary arterial calcification: a review. Am J Med
Sci 1961;41–50.
30. Lachman AS, Spray TL, Kerwin DM, Shugoll GI, Roberts WC.
Medial calcinosis of Monckeberg. A review of the problem and a
description of a patient with involvement of peripheral, visceral and
coronary arteries. Am J Med 1977;63:615–22.
31. Edmonds ME, Foster AVM, Bates M, Wilson S, Salisbury J.
Monckeberg’s medial wall calcification in the coronary arteries of
diabetic patients (abstr). Diabetic Med 1999;16: Suppl 1:42.
2167JACC Vol. 36, No. 7, 2000 Colhoun et al.
December 2000:2160–7 Coronary Calcification in Type 1 Diabetes
